Latest filing published 14 Feb 2022 for DiaMedica Therapeutics Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Amy Louise Burroughs: trading record in brief
Amy Louise Burroughs discloses dealings in DiaMedica Therapeutics Inc. to SEC (Form 4). Between 15 July 2021 and 16 August 2021, the trades on record add up to 2 filings.
No open-market sale appears; the market trades are 1 purchase worth €96k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2022: 1 purchase and no sales on the market.
On 14 February 2022 came the latest disclosure, a transaction in DiaMedica Therapeutics Inc. The last purchase on record was published on 14 February 2022, which is 1,730 days ago. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Amy Louise Burroughs
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- Common SharesTSXSEDI:3885097
- 44,950 shares@ CA$3.15100.0% of flowCommon SharesTSXSEDI:3885098Canonical exit: 14 Nov 2021 (T+90)
2 of 2 declarations